Public health policy in the UK related to nutrition and bone health has been shaped by reports from the Department of Health (DH), Food Standards Agency and WHO. Dietary reference values (DRV) for a number of nutrients were published in 1991 by the DH Committee on Medical Aspects of Food and Nutrition Policy. The subsequent DH report on nutrition and bone health in 1998 concentrated particularly on Ca and vitamin D, but also briefly addressed the effect of body weight, alcohol and other nutrients. Although this reviewed more recent evidence relating to the effect of higher intakes of Ca and vitamin D from longitudinal and interventional studies, no changes were made to the existing DRV. The Food Standards Agency published a report from their Expert Group on Vitamins and Minerals in 2003, which recommended safe upper limits for eight vitamins and minerals, with guidance provided on a further twenty-two nutrients, where there was less information on safety. The WHO report on diet, nutrition and the prevention of chronic diseases in 2003 addressed the prevention of osteoporosis, making recommendations on Ca, vitamin D, Na, fruit and vegetables, alcohol and body weight. The present paper examines current views on what constitutes an adequate dietary Ca intake and optimal vitamin D status, the DRV for vitamin D in subjects with little or no exposure to sunlight and the results of recent epidemiological studies on the relationship between fracture risk and body weight, alcohol intake and the consumption of other nutrients.
Bone diseases such as osteoporosis and osteomalacia are a major cause of excess mortality, morbidity and health and social services expenditure in older individuals, because of their association with low trauma fractures and skeletal deformity. The importance of Ca and vitamin D in the maintenance of bone health has stimulated interest in the potential role of other nutritional factors.
A number of reports and documents have shaped and influenced public health policy on nutrition and bone health in the UK. The UK Department of Health Committee on Medical Aspects of Food and Nutrition Policy (COMA) report on dietary reference values (DRV) in 1991 included nutrients relevant to bone health 1 . The Department of Health Advisory Group on Osteoporosis report in 1994 suggested that DRV should be reviewed, in the light of more recent studies 2 . This was undertaken in the Department of Health report on nutrition and bone health in 1998, which particularly concentrated on Ca and vitamin D 3 . Other nutritional factors were addressed briefly, including body weight, protein, vitamins K and C, Mg, P, Na, K, fluorine, alcohol, caffeine and phyto-oestrogens 3 . The Food Standards Agency Expert Group on Vitamins and Minerals published a report on safe upper limits of nutrients in 2003, which included a detailed review of nutritional and toxicological data on thirty-four vitamins and minerals 4 . Safe upper limits were recommended for eight of the nutrients, whilst guidance was provided for twenty-two vitamins and minerals where the evidence was less clear, including those related to bone health. Ca supplementation up to 1500 mg/d was regarded as safe, as was vitamin D up to 25 mg (1000 IU) daily and vitamin A up to 1500 mg retinol equivalents daily 4 . The WHO published a report on diet, nutrition and the prevention of chronic diseases in 2003 5 . The osteoporosis section suggested that in countries with a high fracture incidence, low Ca intake (, 400-500 mg/d) was associated with increased risk in older individuals. It was suggested that an increase in dietary intake of vitamin D and Ca in this group could reduce fracture risk. If sunshine exposure was limited, a vitamin D intake of 5-10 mg (200 -400 IU) daily was also recommended. This report also summarised the evidence that other nutritional factors either increased or decreased the risk of fracture 5 . Although many studies have examined the effect of nutrition on markers of bone health, such as biochemical markers of bone turnover and bone mineral density (BMD), fracture is the most important outcome measure.
Dietary requirements for calcium
DRV for Ca were set by the Committee on Medical Aspects of Food and Nutrition Policy in 1991, based on factorial calculations which take into account the efficiency of Ca absorption, obligatory losses in the faeces, urine and sweat and the requirements for growth in childhood 1 . The reference nutrient intake (RNI) of 700 mg/d for adults, which should provide sufficient Ca for 97·5 % of the adult population, is two standard deviations above the estimated average requirement of 550 mg/d. The lower RNI is 400 mg/d, below which dietary Ca is likely to be inadequate, is two standard deviations lower than the estimated average requirement. No other measure of bone health was considered in 1991, but the subsequent report in 1998 examined the effects of high Ca intakes on BMD and fracture incidence in longitudinal and intervention studies 3 . This report endorsed the earlier DRV (Table 1) , but it was felt that the additional 550 mg/d in lactation was probably unnecessary.
Dietary calcium intake in the United Kingdom
The major source of Ca is dairy produce, but other Ca-rich foods include flour, cereals, fish such as sardines and vegetables such as spinach and broccoli. The National Diet and Nutrition Survey showed that 79 % of boys and girls aged 11-14 years have a dietary Ca intake lower than the RNI, with 12 % of boys and 24 % of girls in this age group having an intake below the lower RNI 6 . In contrast, only 2 % of men and 5 % of women aged 19 -64 years have a dietary intake below the lower RNI 7 . In older women, the proportion with a Ca intake below the lower RNI increases from 8 % between the ages of 65 and 74 years to 15 % at 85 years and older, whereas the corresponding figures for men are 4 % and 2 % respectively 8 .
Calcium supplementation
In view of the potentially inadequate dietary Ca intake in children and older individuals, it is important to review the effects of supplementation on bone health. A recently published meta-analysis of fifteen randomised controlled trials involving 2859 children examined the effects of the addition of 300-1200 mg elemental Ca in supplementation or dairy produce 9 .
The duration of Ca supplementation ranged from 8 months to 4 years and post-supplementation follow up from 8 months to 8 years. This meta-analysis concluded that there was no significant effect of Ca supplementation on femoral neck or lumbar spine BMD. There was a small effect on total body bone mineral content and upper-limb BMD, but it is felt that this was unlikely to influence the risk of subsequent fractures. There is some debate about the appropriateness of using BMD as a single marker of bone health in children and adolescents, where considerations about skeletal mass and size are also required 10 . A meta-analysis of Ca supplementation examined fifteen randomised controlled trials in 1806 postmenopausal women with BMD or fractures as outcome measures 11 . Ca decreased bone loss by 1·66 (95 % CI 0·92, 2·39) % at the spine, 1·64 (95 % CI 0·70, 2·57) % at the hip and 2·05 (95 % CI 0·24, 3·86) % for total body BMD. Despite this beneficial effect on bone loss, there was no reduction in the risk of vertebral fractures (relative risk 0·77 (95 % CI 0·54, 1·09)) or non-vertebral fractures (relative risk 0·86 (95 % CI 0·43, 1·72)).
The Women's Health Initiative Study of Ca and vitamin D supplementation was performed in 36 282 post-menopausal women aged 50 -79 years 12 . These were randomised to receive Ca (1000 mg) and vitamin D (10 mg; 400 IU) or placebo daily. Although Ca and vitamin D supplementation resulted in a small beneficial effect on bone loss, there was no overall reduction in fractures, clinical vertebral fractures or hip fractures. Post hoc analysis suggested that Ca and vitamin D supplementation decreased the risk of fractures in older individuals and in those who remained compliant with treatment. Nevertheless, any potential benefits were offset by an increased risk of renal stones (hazard ratio 1·17 (95 % CI 1·02, 1·34)). Other studies show that although Ca supplementation increases the risk of renal stones, a high dietary intake of Ca is associated with a lower risk of renal stones 13 . The results of these studies suggest that the DRV for Ca in the UK are appropriate and do not support the routine use of Ca supplementation in the general population. Nevertheless, a significant proportion of younger adolescents and older individuals have a dietary Ca intake lower than the DRV and may benefit from an increased Ca intake.
Dietary requirements for vitamin D
The major source of vitamin D is cutaneous production, following exposure to UV radiation. The diet generally provides smaller amounts of vitamin D, but this source is essential when cutaneous production is limited, because of lack of exposure to sunlight. The major dietary sources of vitamin D are fortified margarine and other fat spreads, cereals, oily fish, meat eggs and dairy produce. The most important consequence of vitamin D deficiency is the development of osteomalacia, which is characterised by an impairment of bone mineralisation and accumulation of osteoid. The DRV for vitamin D set in 1991 were based on the dietary amount required to ensure that the serum 25-hydroxyvitamin D (25OHD) in winter was above 20 nmol/l, as vitamin D-deficiency osteomalacia generally only occurs in individuals with lower circulating concentrations 1 . When the DRV for vitamin D . No RNI was set for children above the age of 3 years or adults below the age of 65 years, unless they were considered at risk of vitamin D deficiency (because of strict dress code, being house-bound or having increased skin pigmentation) when an RNI of 10 mg (400 IU) daily was set. It is important to consider if this RNI is adequate in individuals with no cutaneous production of vitamin D, such as completely veiled women or submariners. In the latter group, vitamin D intakes of 15 mg (600 IU) daily are required to maintain serum 25OHD at its previous level 14 . As the mean intake of vitamin D from food sources in adults in the UK ranges 2·0-4·0 mg (80-160 IU) daily 7, 8 , most individuals at risk of developing vitamin D deficiency will require supplementation. This should probably be administered as vitamin D 3 (cholecalciferol) rather than vitamin D 2 (ergocalciferol), as there is evidence suggesting that the metabolism of the latter may be impaired 15 . In a study of twenty normal healthy men, a single oral dose of 1·25 mg (50 000 IU) of either vitamin D 2 or vitamin D 3 was administered, following which the change in serum 25OHD was monitored over a 28 d period. Although there were similar increases in serum 25OHD in the first 3 d after the administration of vitamin D 2 and vitamin D 3 , at the end of the study the serum 25OHD was 50 nmol/l above baseline after vitamin D 3 administration, but was 5 nmol/l lower than the initial value in the vitamin D 2 -treated group 15 .
Vitamin D deficiency in the United Kingdom
The prevalence of vitamin D deficiency in older individuals in the UK was examined in the National Diet and Nutrition Survey 8 . Using a threshold value of serum 25OHD of , 25 nmol/l, the prevalence of vitamin D deficiency increased from 5-6 % between the ages of 65 and 74 years to 13-25 % above the age of 85 years. The prevalence of vitamin D deficiency in care-home residents was higher than 36 %. Similar findings were reported in the recent Health Survey for England 16 . Although classically vitamin D deficiency has been associated with osteomalacia, there has been growing interest in the role of vitamin D insufficiency and secondary hyperparathyroidism in the development of osteoporosis and low trauma fractures 17 . There is an inverse relationship between serum 25OHD and parathyroid hormone, but no clear evidence of a threshold value of 25OHD above which parathyroid hormone reaches a plateau 18 . The relationship between 25OHD and parathyroid hormone may be used to establish a threshold value for vitamin D insufficiency, but there is no clear agreement on the appropriate level to select , a recent review suggests that intakes as high as 250 mg (10 000 IU) daily are safe 24 , at least in the short term.
Vitamin D supplementation
A meta-analysis of vitamin D supplementation published in 2005 indicated that doses of 17·5·20 mg (700-800 IU) daily decreased the risk of hip and other non-vertebral fractures, whereas lower doses (10 mg; 400 IU daily) were ineffective 25 . A number of recent studies cast doubt on the role of vitamin D supplementation, with or without Ca, in the prevention of fractures in older individuals 12,26 -30 . A recent Cochrane review 31 , which includes some of these recent studies 26 -28 , suggests that vitamin D used alone has no significant effect on hip fracture (seven trials; 18 668 participants; relative risk 1·17 (95 % CI 0·98, 1·41)). In contrast, combined supplementation with vitamin D and Ca marginally reduced the risk of hip fractures (seven trials; 10 376 participants; relative risk 0·81 (95 % CI 0·68, 0·96)), but the effect appeared to be restricted to those living in institutional care 31 . Another recent meta-analysis also shows a similar reduction in hip fractures with Ca and vitamin D (relative risk 0·82 (95 % CI 0·71, 0·94)), with no beneficial effect of vitamin D alone on fracture incidence 32 . Two recent studies have examined the effects of vitamin D in care-home residents, who are likely to be vitamin D deficient 29, 30 . Law performed a cluster randomised trial of oral vitamin D 2 (2·5 mg; 100 000 IU) three-monthly in 3717 care-home residents 29 . Serum 25OHD in a small sub-set increased from 47 to 82 nmol/l after 1 month and 74 nmol/l after 3 months. Despite this improvement in vitamin D status, there was no reduction in falls (relative risk 1·09 (95 % CI 0·95, 1·25)) or fractures (relative risk 1·48 (95 % CI 0·99, 2·20)). A second randomised controlled trial by Lyons et al. examined the effect of oral vitamin D 2 (2·5 mg; 100 000 IU) four-monthly in 3440 care-home residents 30 . Baseline serum 25OHD measurements were not performed, but during the study these were 80 and 54 nmol/l respectively in a small sub-set of the intervention and control group. There was no reduction in fracture risk with vitamin D supplementation (hazard ratio 0·95 (95 % CI 0·8, 1·20)).
Although there is controversy about what constitutes adequate vitamin D status, the recent studies of vitamin D supplementation suggest that the conservative thresholds adopted in the UK may be more appropriate than those advocated in North America. Combined Ca and vitamin D supplementation may decrease fracture risk in care-home residents, in whom vitamin D deficiency is common, but is probably ineffective in the prevention of fractures in community-dwelling older individuals. Future studies of vitamin D supplementation should include measurements of vitamin D status in a greater proportion of the participants than in previous trials, to investigate the relationship between putative benefits and the baseline and peak serum 25OHD concentrations achieved with supplementation.
Other nutritional factors
The effect of low BMI was examined in a recent meta-analysis in 14 887 men and 44 757 women from twelve prospective cohort studies 33 . This showed little effect of BMI on fracture risk between 25 There has been growing interest in the role of fruit and vegetables in the maintenance of bone health. Studies show a beneficial effect on bone density and bone turnover markers, but there is no evidence yet of a reduction in fracture risk 35 . It is also currently unclear if the putative benefits of fruit and vegetable consumption are mediated in changes in acid -base balance, vitamin K or the consumption of antioxidants.
Although our knowledge of the effects of nutrition on bone health is gradually increasing, there are still a large number of unanswered questions. It is therefore important to remember Voltaire, who stated that 'only charlatans are certain. . . doubt is not a very agreeable state, but certainty is a ridiculous one.'
